2013-05-15 – Page 4 – China Stock Advice

BSPM [Biostar Pharmaceuticals,] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x March 31, 2013 For the quarterly period ended: Or ¨ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 86-29-33686638 (Former name, former] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this Quarterly 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period] [CERTIFICATION I, Qinghua Liu, certify that: 1. I have reviewed this Quarterly 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Dated: May 15, 2013 Ronghua Wang Chief Executive Officer EX-32.1 4 ex32-1.htm] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Dated: May 15, 2013 Qinghua Liu Interim Chief Financial Officer (principal financial officer) EX-32.2 5 ex32-2.htm]

By info| 2016-03-03T11:04:31+00:00 May 15th, 2013|Categories: BSPM, Chinese Stocks, SEC Original|Tags: 0001418133, 10-Q, 2013-05-15, 2834, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

BSPM [Biostar Pharmaceuticals,] 10-Q: FORM 10-Q (Mark One) x March 31, 2013

[FORM 10-Q (Mark One) x March 31, 2013 For the quarterly period ended: Or ¨ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 86-29-33686638 (Former name, former] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this Quarterly 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period] [CERTIFICATION I, Qinghua Liu, certify that: 1. I have reviewed this Quarterly 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Dated: May 15, 2013 Ronghua Wang Chief Executive Officer EX-32.1 4 ex32-1.htm] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Dated: May 15, 2013 Qinghua Liu Interim Chief Financial Officer (principal financial officer) EX-32.2 5 ex32-2.htm]

By info| 2016-03-03T11:06:26+00:00 May 15th, 2013|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: 0001418133, 10-Q, 2013-05-15, 2834, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

CNET [ChinaNet Online] 8-K: (Original Filing)

[ChinaNet Online Holdings, Inc. Preannounces First Quarter 2013 Revenues of $7 million Files Extension for Q1 2013 10-Q Filing BEIJING, May 15, 2013 (GLOBE NEWSWIRE) -- ChinaNet Online Holdings, Inc. (Nasdaq:CNET) (the "Company" or "ChinaNet"), a leading B2B (business to business) Internet technology company focusing on providing online-to-offline ("O2O") sales channel expansion services for small businesses (small and medium-sized enterprises]

By info| 2016-03-04T20:38:21+00:00 May 15th, 2013|Categories: Chinese Stocks, CNET, SEC Original|Tags: 0001376321, 2013-05-15, 7311, 8-K, CNET, SERVICES-ADVERTISING AGENCIES|0 Comments

EVK [Ever-Glory International,] 10-Q/A: (Original Filing)

[FORM 10-Q/A Amendment No. 1 x For the quarterly period ended June 30, 2012 o For the transition period from ____________ to ____________ Ever-Glory International Florida 65-0420146 (State or other jurisdiction oforporation or organization) (I.R.S. Employer Identification No.) Ever-Glorymmercial Center, 509 Chengxin Road, Jiangning Development Zone, Nanjing, Jiangsu Province,] [1. I have reviewed this Amendment No. 1 to thequarterly report on Form 10-Q for the period ended June 30, 2012 of Ever-Glory International,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [I, Jiansong Wang, certify that: 1. I have reviewed this Amendment No. 1 to the quarterly report on Form 10-Q for the period ended June 30, 2012 of Ever-Glory International,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to] [Section 906 ofrbanes-Oxley Act of 2002 1. 2. The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany. Edward Yihua Kang Chief Executive Officer f10q0612a1ex32i_everglory.htm 4 EX-32.1] [Section 906 ofrbanes-Oxley Act of 2002 1. 2. The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany. Jiansong Wang Chief Finance Officer (Principal Financial Officer) f10q0612a1ex32ii_everglory.htm 5 EX-32.2]

By info| 2016-02-07T04:43:47+00:00 May 15th, 2013|Categories: Chinese Stocks, EVK, SEC Original|Tags: 0000943184, 10-Q.A, 2013-05-15, 2300, APPAREL and OTHER FINISHED PRODS OF FABRICS and SIMILAR MATERIAL, EVK|0 Comments

CNET [ChinaNet Online] 8-K: ChinaNet Online Holdings, Inc. Preannounces First Quarter 2013

[ChinaNet Online Holdings, Inc. Preannounces First Quarter 2013 Revenues of $7 million Files Extension for Q1 2013 10-Q Filing BEIJING, May 15, 2013 (GLOBE NEWSWIRE) -- ChinaNet Online Holdings, Inc. (Nasdaq:CNET) (the "Company" or "ChinaNet"), a leading B2B (business to business) Internet technology company focusing on providing online-to-offline ("O2O") sales channel expansion services for small businesses (small and medium-sized enterprises]

By info| 2016-03-04T20:39:59+00:00 May 15th, 2013|Categories: Chinese Stocks, CNET, Webplus ver|Tags: 0001376321, 2013-05-15, 7311, 8-K, CNET, SERVICES-ADVERTISING AGENCIES|0 Comments

EVK [Ever-Glory International,] 10-Q/A: FORM 10-Q/A Amendment No. 1 x For the

[FORM 10-Q/A Amendment No. 1 x For the quarterly period ended June 30, 2012 o For the transition period from ____________ to ____________ Ever-Glory International Florida 65-0420146 (State or other jurisdiction oforporation or organization) (I.R.S. Employer Identification No.) Ever-Glorymmercial Center, 509 Chengxin Road, Jiangning Development Zone, Nanjing, Jiangsu Province,] [1. I have reviewed this Amendment No. 1 to thequarterly report on Form 10-Q for the period ended June 30, 2012 of Ever-Glory International,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [I, Jiansong Wang, certify that: 1. I have reviewed this Amendment No. 1 to the quarterly report on Form 10-Q for the period ended June 30, 2012 of Ever-Glory International,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to] [Section 906 ofrbanes-Oxley Act of 2002 1. 2. The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany. Edward Yihua Kang Chief Executive Officer f10q0612a1ex32i_everglory.htm 4 EX-32.1] [Section 906 ofrbanes-Oxley Act of 2002 1. 2. The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany. Jiansong Wang Chief Finance Officer (Principal Financial Officer) f10q0612a1ex32ii_everglory.htm 5 EX-32.2]

By info| 2016-02-07T04:44:41+00:00 May 15th, 2013|Categories: Chinese Stocks, EVK, Webplus ver|Tags: 0000943184, 10-Q.A, 2013-05-15, 2300, APPAREL and OTHER FINISHED PRODS OF FABRICS and SIMILAR MATERIAL, EVK|0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 10-Q: (Original Filing)

[] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. May 15, 2013 Weibing Lu Chief Executive Officer EX-32.1 4 v344542_ex32-1.htm EX-32.1] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. May 15, 2013 Bing Mei Chief Financial Officer EX-32.2 5 v344542_ex32-2.htm EX-32.2]

By info| 2016-03-01T04:19:41+00:00 May 15th, 2013|Categories: Chinese Stocks, SEC Original, SKBI|Tags: 0001076939, 10-Q, 2013-05-15, 2834, PHARMACEUTICAL PREPARATIONS, SKBI|0 Comments

CNET [ChinaNet Online] NT 10-Q: (Original Filing)

[]

By info| 2016-03-04T20:41:22+00:00 May 15th, 2013|Categories: Chinese Stocks, CNET, SEC Original|Tags: 0001376321, 2013-05-15, 7311, CNET, NT_10-Q, SERVICES-ADVERTISING AGENCIES|0 Comments

CLNT [Cleantech Solutions International,] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x For the quarterly period ended March 31, 2013 o For the transition period from __________ to __________ CLEANTECH SOLUTIONS INTERNATIONAL, NEVADA 90-0648920 (State or other jurisdiction oforporation of organization) (I.R.S. Employer Identification No.) No. 9 Yanyu Middle Road Qianzhou Village, Huishan District, Wuxi City] [SARBANES-OXLEY ACT OF 2002 I, Jianhua Wu, certify that: 1.I have reviewed this quarterly report on Form 10-Q of Cleantech Solutions International,; 2.Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances] [CERTIFICATION OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICERRBANES-OXLEY ACT OF 2002 I,am Wasserman, certify that: 1.I have reviewed this quarterly report on Form 10-Q of Cleantech Solutions International,; 2.Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany. May 15, 2013 Jianhua Wu ChiefExecutive Officer May 15, 2013am Wasserman ChiefFinancial Officer (Principal Accounting Officer)]

By info| 2016-02-02T22:49:38+00:00 May 15th, 2013|Categories: Chinese Stocks, CLNT, SEC Original|Tags: 0000819926, 10-Q, 2013-05-15, 3550, CLNT, SPECIAL INDUSTRY MACHINERY (NO METALWORKING MACHINERY)|0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 10-Q:

[] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. May 15, 2013 Weibing Lu Chief Executive Officer EX-32.1 4 v344542_ex32-1.htm EX-32.1] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. May 15, 2013 Bing Mei Chief Financial Officer EX-32.2 5 v344542_ex32-2.htm EX-32.2]

By info| 2016-03-01T04:20:47+00:00 May 15th, 2013|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: 0001076939, 10-Q, 2013-05-15, 2834, PHARMACEUTICAL PREPARATIONS, SKBI|0 Comments